In addition, the Angiotensin II type 1 receptor antagonists (ARBs), used for the treatment of BP (blood pressure) and as renal- and cardio-protective agents, are currently regarded as novel pharmacological tools to normalize blood vessel network in cancer [52,53,138]. Here, AGTR1 is linked to cancer.